ArticlePLoS medicine2024

Impact and cost-effectiveness of the 6-month BPaLM regimen for rifampicin-resistant tuberculosis in Moldova: A mathematical modeling analysis.

Lyndon P James et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.